eYantra Ventures Q1 FY27: Revenue Steady, Loss Widens as Cost Mix Shifts

Revenue from operations was INR 1,917.42 lakhs (INR 19.1742 crore) for the quarter ended 30-06-2026 on a consolidated basis.

The group reported a loss before tax of INR 357.50 lakhs (INR 3.5750 crore) and a net loss for the period of INR 374.95 lakhs (INR 3.7495 crore) for the quarter ended 30-06-2026.

For the quarter ended 30-06-2026, revenue included Sale of FMCG and services (INR 1,235.73 lakhs), Supply of IT services (INR 526.35 lakhs), Income from hospital services (INR 153.99 lakhs), and Sale of pharmacy products (INR 35.15 lakhs). Supply of other services was shown as nil.

Within India revenue was INR 1,782.45 lakhs and Outside India revenue was INR 134.97 lakhs for the quarter ended 30-06-2026, on a consolidated basis.

The limited review report states the consolidated statement includes Prismberry Technologies Private Limited and eYantra Ventures FZE, UAE as wholly owned subsidiaries, and Neuro and Spine Associates Private Limited as a subsidiary.

The Board decided on 02-07-2026 to close or strike off eYantra Ventures FZE, UAE, described as a non-functioning wholly owned subsidiary. The financial information for this subsidiary was stated as not reviewed by its auditor and included nil revenue and a loss of INR 17.35 lakhs for the quarter.